Elle Aydogan, holds a Masters in Laboratory Medicine majoring in Haematology. Developing a keen interest in Flow Cytometry (FCM), Elle joined the Clinical FCM Laboratory at Peter MacCallum Cancer Centre (PMCC). Her work there involved isolating plasma cells for genomic research, resulting in a publication. Elle furthered her knowledge in FCM and immunophenotyping under the guidance of Vuong Nguyen. Elle's journey continued in the ResearchFlowCore at PMCC, where she completed the International Specialist in Cytometry Certification(2022). Currently, Elle is actively involved in expanding her knowledge of FCM and its applications in Cancer Research, led by Eva Orlowski-Oliver and the team.

Kathryn is the Director of Chameleon Science, an Australian company specialising in the distribution of emerging life science technologies. Following a BSc at University of Sydney, Kathryn began her flow career working for Caltag Medsystems in London, and since then has worked for Becton Dickenson, Australian Biosearch, Biolegend, Phitonex, and Thermo Fisher. She was awarded an MBA from the Australian Institute of Business in 2018. Over her time in the industry, Kathryn developed a passion for emerging technologies and has recently set up her own business aimed at introducing these to researchers in Australia and NZ.

Kathryn is the Director of Chameleon Science, an Australian company specialising in the distribution of emerging life science technologies. Following a BSc at University of Sydney, Kathryn began her flow career working for Caltag Medsystems in London, and since then has worked for Becton Dickenson, Australian Biosearch, Biolegend, Phitonex, and Thermo Fisher. She was awarded an MBA from the Australian Institute of Business in 2018. Over her time in the industry, Kathryn developed a passion for emerging technologies and has recently set up her own business aimed at introducing these to researchers in Australia and NZ.

Edwin holds a PhD in experimental medicine and is the advanced flow cytometry specialist at Westmead Cytometry that is part of the Westmead Research Hub, in the largest health and medical research precinct in the southern hemisphere. Edwin is an active member of the Australasian Cytometry Society and regularly attends and presents at Cytometry conferences and workshops.

Eva Orlowski-Oliver, SCYM(ASCP), is the Research Flow Core Manager at the Peter McCallum Cancer Centre in Melbourne, Australia. Her role involves educating, training, and supporting research staff who utilise flow cytometry technology. She also encourages her team to participate in society task forces, conduct SRL experiments, and engage in continuous education and training to enhance their skills.

Isabelle Coenen is a research assistant with the pregnancy and early life immunology team at Telethon Kids Institute. Her work focuses on developing full spectrum flow cytometry panel to characterise human B-cell subsets.

Dr Contreras studies tissue regeneration and homeostasis loss in mammals, focusing on the stem cell and stromal compartments. His work identified fibro-adipogenic progenitors (FAPs) as drivers of tissue regeneration and disease. Dr Contreras leverages in vivo and cell-based 3D systems to explore mammalian heart and muscle development, congenital disease pathophysiology, and tissue regeneration. Recognized for research and leadership, he serves on committees, advisory boards, and scientific societies. As an ECR, Dr Contreras promotes open research, scientific culture, diversity, and equality. He is a preLighter, member of the Postdoctoral and Diversity Committees, eLife Community Ambassador, and founder of the IUBMB Trainee Initiative.

Mae is a Masters student from the Department of Microbiology and Immunology at the University of Otago where she also completed her undergraduate degree in Microbiology in 2021.

Katherine is a Technical Application Specialist at Cytek, supporting ANZ. With extensive experience managing a cytometry core facility, Katherine made her move to Cytek in 2019, where her dedication to quality cytometry and teaching best practices could reach a broader audience. Sam Small is a senior staff scientist and cell sorting specialist in the Hugh Green Cytometry Centre at the Malaghan Institute of Medical Research. Within her time there she has had a large role in embedding full spectrum flow cytometry technology and establishing best practices for its use.

Associate Professor Peter Wookey is research director with co-director Professor David Hare for a group including four PhD students in the Department of Medicine-Austin, University of Melbourne, Australia. We have developed first-in-class monoclonal antibodies that bind extracellular epitopes of G protein-coupled receptors including calcitonin (CT) receptor. Such antibodies are slowly accumulated into live cells making them suitable vectors for treatment of diseased cells and imaging of stressed cells that express CT Receptor. One antibody conjugate CalRexinTM:568 has been deployed to measure apoptosis by FACS and confocal imaging, and is now a proprietary reagent of Apop Biosciences, founded by Dr Wookey.

Dr Farah Azima Abdul Muttlib is a Pathologist (Hematologist) working in Children Specialist Hospital National University of Malaysia, Kuala Lumpur, Malaysia. She has actively participated in various hemato-oncology and thalassaemia research conducted in the institute. Her works were related to various specialized tests involving diagnostic and consultation for hemato-oncology and red cell membrane disorder namely molecular PCR for acute leukaemia, mutation analysis of leukaemia, cytogenetic analysis for hemato-oncology, beta and alpha thalassemia diagnosis as well as 5-years experience in leukaemia flowcytometry analysis. Her current research interest is mainly focus on haematological disorders specifically in hemato-oncology.

Established the leukemia diagnosis unit at national oncology center, Sana’a and the flow cytometry service in Yemen. Bachelor of Science in Medical laboratories from Sana’a University and Master of Science in Medical laboratory Science with specializing in Hematology and Blood Banking from University of Science and Technology, Irbid, Jordan. Interested in the field of development (scientific, practical and administrative) and continuous education and practical training in the field of hematology laboratory, in general, and in leukemia biology, in particular. Making all efforts to obtain various experiences in the same field, and to continuously develop the experiences I obtain.

Esther Aklilu is the Flow cytometry senior scientist at Royal Prince Alfred hospital in Sydney. She has working in both research and clinical flow cytometry laboratories for the past 15-years. From research she branched out to diagnostic flow cytometry. She is now supervises a highly specialised flow cytometry laboratory which performs Oncology immunophenotyping, Feto-maternal haemorrhage quantitation, Paroxysmal nocturnal hemoglobinuria testing, hereditary spherocytosis screening and measurable residual disease testing for Myeloma and CLL.

Ceridwyn is currently in the second year of her PhD at Te Herenga Waka Victoria University of Wellington. Her research focuses on neutrophil-mediated inflammation in the acute inflammatory response that ensues post-acute myocardial infarction (AMI; heart-attack). Her current projects involve developing flow cytometry-based methodologies to examine neutrophil extracellular traps (NETs) and neutrophil subsets in human blood. Ceridwyn aims to use these methodologies in clinical samples from AMI patients to identify novel avenues for therapeutic intervention in patients experiencing pathological inflammation.